title: For Bexxar, FDA meeting offers long-awaited chance at approval.
authors.forename: Ken
authors.initials: K
authors.lastname: Garber
mesh_terms: D000911:Antibodies, Monoclonal; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; C119496:tositumomab I-131